Quantcast

Latest Seizure types Stories

2011-03-01 18:01:00

WASHINGTON, March 1, 2011 /PRNewswire-USNewswire/ -- Christopher Garske, 16, of Wantagh, and Josh Silverman, 17, of Lake, will travel to Washington, D.C., to raise awareness about epilepsy and how it affects the life of a child who experiences seizures. They will participate in the Epilepsy Foundation's annual Kids Speak Up! event from March 27 through March 29, and become a part of the democratic process to make a difference for the nearly 3 million people coping with the disorder. Kids...

2010-10-01 14:25:38

More than 50 percent reduction in partial seizure frequency; safety, efficacy confirmed Researchers from the Arkansas Epilepsy Program found treatment with rufinamide results in a significant reduction in seizure frequency compared with placebo, for patients with uncontrolled partial-onset seizures (POS). Details of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy. Epilepsy affects up to 2% of the...

2010-03-22 05:30:00

NEW YORK, March 22 /PRNewswire-USNewswire/ -- Members of the U.S. House and Senate, children in schools across the country, and employees of workplaces nationwide will wear purple to support epilepsy awareness on March 26. Thousands of Americans will also join the campaign by hosting Purple Day activities in their regions. Purple Day was founded in 2008, by nine-year-old Cassidy Megan. Motivated by her own struggles with epilepsy, Cassidy created the day to tell other kids about the...

2010-02-17 07:03:00

CORAL GABLES, Fla., Feb. 17 /PRNewswire/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced today that it was selected by both the Scientific and Business Advisory Boards of the Epilepsy Therapy Project to present at the 2010 Epilepsy Pipeline Update Conference, an in-depth, two day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco. Charles W. Gorodetzky, M.D., Ph.D., Catalyst's Chief Medical Officer will present an overview of CPP-115,...

2010-01-29 16:31:00

RESEARCH TRIANGLE PARK, N.C., Jan. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration has approved Lamictal®XR(TM) (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures. This is an expanded label, as Lamictal XR is approved for partial onset seizures (with or without secondary generalization) for...

2009-11-03 08:05:00

ATLANTA, Nov. 3 /PRNewswire/ -- UCB, an active participant in the epilepsy community for more than a decade, is proudly launching a variety of patient-centered initiatives in honor of Epilepsy Awareness Month in November. These programs are the culmination of years of experience in the epilepsy community and seek to empower patients, improve epilepsy care, and raise awareness about the condition. "At UCB, our goal has always been to make a meaningful and lasting difference in the epilepsy...

2009-11-02 06:00:00

Harnessing the power of professional athletes, who wear helmets in their careers, to help erase the stigma associated with epilepsy. CHICAGO and NEW YORK, Nov. 2 /PRNewswire-USNewswire/ -- November is Epilepsy Awareness Month. The Lennox Gastaut Syndrome Foundation (LGSF) and the American Epilepsy Outreach Foundation (AEOF) has joined with Eisai Pharmaceuticals and Lundbeck Pharmaceuticals to co-host the 1st Annual Helmets for Hope(TM) Campaign. The Helmets for Hope(TM) is an awareness...

2009-08-21 16:15:00

TITUSVILLE, N.J., Aug. 21 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an anti-epileptic drug in development, announced Ortho-McNeil-Janssen Pharmaceuticals, Inc. The NDA, filed in October 2008 by Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) on behalf of Ortho-McNeil-Janssen Pharmaceuticals, Inc. seeks approval to market carisbamate (COMFYDE(TM))...

2009-06-29 00:00:00

S. MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire/ -- Data presented today, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix(R)* (eslicarbazepine acetate; ESL) resulted in a marked and sustained decrease in seizure frequency over the long-term(1). Results from the one-year extension of a pivotal Eslicarbazepine Acetate phase III study were presented at the International Congress for Epilepsy in Budapest, Hungary. Patients not...

2009-06-02 16:01:35

U.S. researchers have found an FDA-approved drug that might prevent genetically caused epilepsy also might help prevent more common forms of the condition. Washington University School of Medicine researchers in St. Louis said they found the drug rapamycin may also help prevent forms of epilepsy caused by brain injury. The scientists determined rapamycin blocks brain changes believed to cause seizures in rats. In a paper last year, the same group showed rapamycin prevents brain changes in...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related